Drug breakdown: Indapamide

02 May 2022
Volume 4 · Issue 5

Abstract

In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #Indapamide

Dr Sharon Rees @reesprescribe

Day 1: Labelled a ‘thiazide-like’ diuretic (as it acts in the distal convoluted tubule), #indapamide is actually a non-thiazide sulfonamide. Derived in the late 1960s from benzamide (found in plants eg autumn crocus), it was designed to retain blood pressure lowering effect, as distinct from diuresis.

Dr Sharon Rees @reesprescribe

Day 2: Oral formation only for #indapamide. In the UK, licensed use for essential hypertension at 2.5 mg once daily, or modified release 1.5 mg once daily.

Dr Sharon Rees @reesprescribe

Day 3: Kinetics #indapamide; good oral absorption, cmax 1–2 hours. Binds to red blood cells and plasma proteins, and is then taken up through vascular walls where it acts. Liver metabolism via CYP3A4 with one active metabolite. Renal excretion (avoid in severe impairment), but ~ 23% gastrointestinal excretion. T½ 15–18 hours.

Dr Sharon Rees @reesprescribe

Day 4: MOA; #indapamide lowers blood pressure mainly via vascular action (as opposed to diuresis) by reducing calcium uptake in vascular smooth muscle, leading to impaired vasoconstriction. Also more vasodilation via increased prostaglandin levels (PGE2 and prostacyclin) and increased bradykinin levels (also all relevant to reduced platelet aggregation). #indapamide also reduces left ventricular hypertrophy.

Dr Sharon Rees @reesprescribe

Day 4 (cont): A major advantage for #indapamide is that as a result of its mechanism of action there is no relevant change to glucose or lipid metabolism, so does not worsen/cause type 2 diabetes (unlike some thiazide diuretics). Can use in combination with other antihypertensives.

Dr Sharon Rees @reesprescribe

Day 5: #indapamide ADEs: common include hypersensitivity reactions, rash and clinically significant electrolyte disturbances eg hypokalaemia; needs pre-therapy and regular monitoring. Rare/serious incl angioedema, renal failure, SCARs, aplastic anaemia, vision disorders (NOT exhaustive).

Dr Sharon Rees @reesprescribe

Day 5 (cont): Up to 8% population have ‘sulfa’ allergy, hence contraindication in SPC/BNF for #indapamide. Relevance re cross-sensitivity to #indapamide is unknown; individual history important.

Dr Sharon Rees @reesprescribe

Day 6: #indapamide DDIs. All NSAIDs re renal failure; multiple interactions can cause electrolyte issues eg NSAIDs, gabapentin, lithium, sertraline. Increased risk arrhythmias eg quinine. All antihypertensives potentiate hypotension. Can increase risk of allergy to allopurinol (NOT exhaustive). Metformin is in the SPC (but not BNF) as a drug–drug interaction for #indapamide re lactic acidosis risk enhanced in renal failure.

Dr Sharon Rees @reesprescribe

Day 7: As a diuretic, #indapamide is a banned substance in arena of sports doping (unless TUE); abuse possible via rapid weight loss and/or dilution of other banned agents from the increased urine volume/changes in urine content, allowing use as a ‘masking agent’.

EARN YOUR CPD CERTIFICATE

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate

In addition to the tweets, read the BNF treatment summaries on diuretics and hypertension, as well as the monograph on indapamide. Another useful source is the Summary of Product Characteristics for indapamide – see links below. Please submit the answers to reesprescribe@gmail.com as a numbered list with TRUE/FALSE or the correct A,B,C,D option. If you achieve 8 or more out of 10 on the questions, a CPD certificate will be emailed to you.

Further reading on #indapamide

  • Diuretics: https://bnf.nice.org.uk/treatment-summary/diuretics.html
  • Hypertension: https://bnf.nice.org.uk/treatment-summary/hypertension.html
  • Indapamide: https://bnf.nice.org.uk/drug/indapamide.html
  • Indapamide 2.5 mg Tablets: https://www.medicines.org.uk/emc/medicine/26709#gref

 

There are lots of formulations for indapamide

TRUE or FALSE?

Indapamide is a loop diuretic

TRUE or FALSE?

Which is TRUE?

  • Indapamide acts in the distal convoluted tubule (DCT), but its main action lowering blood pressure occurs on the blood vessels
  • Indapamide acts in the Loop of Henle and effects powerful diuresis
  • Indapamide dilate veins and increases afterload
  • Indapamide acts at multiple sites in the nephron to exert diuresis

Indapamide is ineffective if the CrCl is below 30 mL/min

TRUE or FALSE?

Indapamide is one of the first line diuretics for the management of hypertension

TRUE or FALSE?

Which of the following is considered to be an advantage of indapamide?

  • Electrolyte disturbances help to give better diuresis
  • Some of the drug is excreted via the gut
  • There is no relevant effect on glucose regulation
  • The drug binds to red blood cells in the systemic circulation

Which of the following is a common adverse drug effect?

  • Vomiting
  • Vertigo
  • Vision disorders
  • Electrolyte disturbances

Indapamide has a ‘severe’ drug-drug interaction with allopurinol

TRUE or FALSE?

Indapamide is the only diuretic which is banned in sports doping testing

TRUE or FALSE?

It is possible to be allergic to indapamide

TRUE or FALSE?